PR Newswire

Hepatocyte Growth Factors (HGFs) Market to Reach USD 141 Million by 2034: Rising Liver Illnesses and Surgical Procedures Driving Demand - Transparency Market Research, Inc.

The global hepatocyte growth factors (HGFs) market is slated to grow on the basis of an exponential rise in the number of liver illnesses. Furthermore, rise in the number of surgical operations is ...
ascopubs.org

Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer

View all available purchase options and get full access to this article. Supported by Rosetrees Trust (M314 and M346), Barts Charity (MGU0511, G-001868, G-002205), and the MRC (MR/R009732/1). The ...
Nasdaq

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

Title: ATH-1105, a small molecule positive modulator of the neurotrophic hepatocyte growth factor system, is neuroprotective when administered prophylactically, therapeutically or in combination with ...
EurekAlert!

Clonogenic hepatocytes drive postnatal liver growth and unlock new avenues for pediatric gene therapy

Fluorescence microscopy image of a mouse liver tissue section marked with different fluorescent reporters. Local hepatocyte groups sharing the same reporter are of clonal origin. “Using spatial ...